Nausea
The most common adverse effect of GLP-1 receptor agonists, linked to slowed gastric emptying. It is usually worst at the start and after each dose increase, easing off over time.
Content reviewed by Dr. David Céspedes
Medical guides
Mounjaro before and after: what to expect month by month, according to the trials
ReadMounjaro reviews: what the trials show and what patients report
ReadOrforglipron (Foundayo), approved by the FDA: the first GLP-1 pill that can be taken without food or water restrictions
ReadOrforglipron (Foundayo): the first GLP-1 pill with no restrictions, and why it isn't available in Spain
ReadRetatrutide: what its phase 3 trial found, and why you can't get hold of it
ReadCagriSema: what it is, what the REDEFINE trials found and why it disappointed
ReadOzempic and Mounjaro side effects: what to expect and how to manage them
ReadMounjaro vs Ozempic: clinical differences, effectiveness and which one suits you
Read
Keep reading
This entry is for information. Your case requires an individual medical assessment.